Revenue Update on Halyard Health Inc(NYSE:HYH)

Halyard Health Inc(NYSE:HYH) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 3, 2016. Earnings per share were $0.45.

Halyard Health Inc (HYH) shares turned negative on Fridays trading session with the shares closing down -0.1 points or -0.28% at a volume of 3,54,195. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $36.36. The peak price level was also seen at $36.36 while the days lowest was $35.96. Finally the shares closed at $36.23. The 52-week high of the shares is $36.81 while the 52-week low is $22.76. According to the latest information available, the market cap of the company is $1,691 M.

Several Insider Transactions has been reported to the SEC. On Sep 8, 2015, Robert E Abernathy (CEO) purchased 10,000 shares at $31.06 per share price.Also, On Sep 2, 2015, Steven E Voskuil (CFO) purchased 1,000 shares at $30.00 per share price.

Halyard Health Inc. seeks to advance health and healthcare by preventing infection eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap surgical drapes and gowns facial protection protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings including post-operative pain management solutions minimally invasive interventional (or chronic) pain therapies closed airway suction systems and enteral feeding tubes focused on pain management and respiratory and digestive health.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *